The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.
| Revenue (TTM) | $6.72B |
| Gross Profit (TTM) | $2.84B |
| EBITDA | $1.14B |
| Operating Margin | 12.90% |
| Return on Equity | 163.80% |
| Return on Assets | 8.32% |
| Revenue/Share (TTM) | $55.18 |
| Book Value | $0.74 |
| Price-to-Book | 117.10 |
| Price-to-Sales (TTM) | 1.51 |
| EV/Revenue | 2.311 |
| EV/EBITDA | 13.29 |
| Quarterly Earnings Growth (YoY) | -50.10% |
| Quarterly Revenue Growth (YoY) | -2.00% |
| Shares Outstanding | $120.93M |
| Float | $120.53M |
| % Insiders | 0.72% |
| % Institutions | 88.33% |
Volatility is currently expanding
The Clorox Company's stock price has dropped by roughly 21% in just 1 month. I'm downgrading CLX to a Sell due to persistent financial weakness and lack of turnaround catalysts. CLX reported a 13% organic sales drop and gross margin contraction of 520 basis points, signaling ongoing operational challenges.
Give your snacks a ghoulish glow-up this season with Hidden Valley's first limited edition holiday release in a glow-in-the-dark bottle. Key Highlights: What It Is: Hidden Valley Ranch's first-ever seasonal feature, taking the classic flavor and introducing a spooky black twist to the iconic creamy formula, all in a glow-in-the-dark bottle made for Halloween.
OAKLAND, Calif., Sept. 23, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.25 per share on the company's common stock.
Clorox is downgraded from hold to sell due to deteriorating fundamentals and unsustainable dividend coverage. Organic sales declined 13% in Q4 despite the GOJO acquisition, with only the international segment showing growth. Long-term debt surged to nearly $4 billion, raising concerns amid a high interest rate environment and declining profitability.
Both Clorox and Kimberly-Clark have raised their dividends for years and offer yields above 5%, but one of them is sitting on a payout that its own management quietly admits may not be sustainable.
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Clorox (CLX). But which of these two stocks presents investors with the better value opportunity right now?
CLX's margin management, innovation and IGNITE strategy support growth, while cost pressures and value-conscious consumers challenge its progress.
When quality dividend stocks drift toward 52-week lows, patient income investors often find their best opportunities hiding in plain sight. Five household names are sitting at beaten-down prices right now, and the yields they are offering demand a closer look.
CLX is using cost savings, ERP optimization and pricing to cushion inflation, but the FY27 gross margin is still projected at 42%.
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Clorox (CLX). But which of these two stocks offers value investors a better bang for their buck right now?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CLX and any ticker you trade — then tracks every position and per-strategy win rate.
